Transcat
Transcat's revenue rose 19.2% to $332 million in fiscal 2026. Its operating margin was 4.0%, down from 6.4% a year earlier. Free cash flow was $20 million, down 24.2%. It paid out $0 million in dividends and buybacks, 2% of free cash flow. The diluted share count rose 1.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
From fiscal 2017 to 2026, earnings per share fell 1.3% a year and net income grew 2.0% a year, as new shares raised the share count by 32% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 1 | 2 | 35 | 2 | 5 |
| Debt incl. finance leases | 48 | 49 | 4 | 33 | 100 |
| Net debt (negative means net cash) | 47 | 48 | −31 | 31 | 96 |
| Net debt to EBITDA | 2.0x | 1.8x | −0.9x | 0.9x | 2.4x |
| Debt to equity | 0.6x | 0.5x | 0.0x | 0.1x | 0.3x |
| Interest coverage | 17.5x | 6.7x | 10.8x | 22.4x | 2.9x |
| Current ratio | 2.1x | 2.4x | 3.1x | 2.3x | 2.3x |
| Quick ratio | 1.7x | 1.8x | 2.6x | 1.9x | 2.0x |
Cash flow
Projections
Project Transcat's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 1 insider bought $98,668 of Transcat shares on the open market, and 2 insiders sold $673,399.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Oksana S. DominachDirector | Sold | 7,312 | $85.60 | $625,907 | Form 4 |
| Aug 7, 2026 | Christopher P. GilletteDirector | Sold | 504 | $94.23 | $47,492 | Form 4 |
| Aug 6, 2026 | Craig D. CairnsDirector | Bought | 1,050 | $93.97 | $98,668 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 | FY26 |
|---|---|---|---|
| Piotroski F-score | 8 of 9 | 3 of 9 | 5 of 9 |
| Rule of 40 | 20.0% | 16.6% | 25.1% |
| Altman Z'' | 6.79 | 4.91 | 3.32 |
| Accruals ratio | −7.8% | −7.3% | −6.8% |
The nine F-score tests
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Pass | Fail | Fail |
| F-score | 8 of 9 | 3 of 9 | 5 of 9 |
Compare
Put Transcat side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Transcat | FY26 | 19.2% | 4.0% | 5.9% | 2.5% | 2.4x | 5 | |
| Resolute Holdings | FY25 | 9.9% | 31.0% | 41.0% | 197.0% | −0.1x | — | Compare |
| Liquidity Services | FY26 | 0.3% | 10.2% | 10.2% | — | — | — | Compare |
| Civeo | FY25 | −6.3% | 0.6% | 0.3% | 1.0% | 2.2x | 6 | Compare |
| Xometry | FY25 | 25.9% | −6.6% | −3.5% | −9.7% | — | — | Compare |
10 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 144 | 155 | 161 | 173 | 173 | 205 | 231 | 260 | 278 | 332 |
| Revenue growth | 17.8% | 7.8% | 3.7% | 7.6% | 0.1% | 18.2% | 12.5% | 12.5% | 7.3% | 19.2% |
| Gross profit | 35 | 37 | 39 | 42 | 46 | 58 | 68 | 84 | 90 | 108 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 8 | 9 | 10 | 11 | 11 | 14 | 16 | 20 | 18 | 13 |
| Net income | 4 | 6 | 7 | 8 | 8 | 11 | 11 | 14 | 14 | 5 |
| Diluted EPS (US$) | 0.64 | 0.81 | 0.95 | 1.08 | 1.03 | 1.50 | 1.40 | 1.63 | 1.57 | 0.57 |
| Diluted shares (millions) | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 |
| Cash flow | ||||||||||
| Cash from operations | 8 | 10 | 13 | 12 | 24 | 18 | 17 | 33 | 39 | 35 |
| Capital expenditure | 5 | 6 | 7 | 7 | 7 | 10 | 9 | 13 | 13 | 15 |
| Free cash flow | 2 | 4 | 6 | 5 | 17 | 7 | 8 | 19 | 26 | 20 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 3 | 3 | 7 | 0 | 5 | 4 | 0 |
| Acquisitions | 7 | 0 | 4 | 13 | 4 | 30 | 9 | 13 | 87 | 82 |
| Stock-based compensation | 0 | 1 | 1 | 1 | 2 | 2 | 3 | 4 | 3 | 8 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 35 | 2 | 5 |
| Debt incl. finance leases | 27 | 23 | 21 | 30 | 20 | 48 | 49 | 4 | 33 | 100 |
| Total assets | 92 | 97 | 105 | 128 | 132 | 178 | 196 | 288 | 385 | 480 |
| Total liabilities | 49 | 46 | 46 | 61 | 57 | 92 | 96 | 62 | 98 | 180 |
| Shareholders' equity | 43 | 51 | 60 | 67 | 75 | 86 | 100 | 225 | 287 | 301 |
| Margins and ratios | ||||||||||
| Gross margin | 24.3% | 24.1% | 24.4% | 24.5% | 26.6% | 28.5% | 29.6% | 32.3% | 32.1% | 32.6% |
| Operating margin | 5.5% | 5.8% | 6.4% | 6.3% | 6.4% | 6.9% | 7.0% | 7.6% | 6.4% | 4.0% |
| Net margin | 3.1% | 3.8% | 4.4% | 4.7% | 4.5% | 5.5% | 4.6% | 5.3% | 5.2% | 1.6% |
| Free cash flow margin | 1.6% | 2.6% | 3.5% | 2.9% | 9.8% | 3.6% | 3.3% | 7.5% | 9.3% | 5.9% |
| Rule of 40 (growth + FCF margin) | 19.4% | 10.4% | 7.2% | 10.5% | 10.0% | 21.9% | 15.8% | 20.0% | 16.6% | 25.1% |
| Return on capital | 7.9% | 9.4% | 10.3% | 10.2% | 9.1% | 10.7% | 9.2% | 8.6% | 5.5% | 2.5% |
| Return on equity | 11.0% | 12.5% | 12.9% | 12.7% | 11.0% | 14.1% | 11.5% | 8.4% | 5.7% | 1.8% |
| Return on assets | 5.4% | 6.3% | 7.1% | 6.9% | 6.0% | 7.3% | 5.7% | 5.7% | 4.3% | 1.2% |
| Net debt to EBITDA | 1.9x | 1.5x | 1.2x | 1.7x | 1.0x | 2.0x | 1.8x | −0.9x | 0.9x | 2.4x |